PT-141 (Bremelanotide) Reconstitution Calculator
Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Work the dose out from body weight
Syringe size:
Possible vial strengths:
Best Match
Good Match
Usable
Harder to Measure
Example PT-141 (Bremelanotide) Titration Schedule
| Parameter | Details |
|---|---|
| Dose | 1.75 mg SC (fixed) |
| Timing | ≥45 min pre-activity |
| Max frequency | 1 dose per 24 h; ≤8/month |
| Duration | 4–12 h (label: unknown) |
FDA-approved (Vyleesi). Corrections from the label: the dose is 1.75 mg flat (no 1–4 mg range), frequency is 24 hours not 72 (the stated desensitization rationale is not the label's — its reasons are blood pressure and hyperpigmentation), and duration is unknown per the label (trials showed 4–12 h, not 24–72). Indicated for premenopausal women; male use is off-label.
Possible vial strengths:
What Is It?
PT-141 (Bremelanotide)
Melanocortin agonist studied in sexual response research.
Bacteriostatic Water
Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.
How To Mix PT-141 (Bremelanotide)
1
CleanUse alcohol swabs to clean the tops of both vials.
2
Draw BAC WaterDraw the selected amount of bacteriostatic water.
3
Inject SlowlyAdd the liquid slowly down the side of the vial.
4
Swirl GentlyDo not shake. Swirl gently until dissolved.
5
Store ProperlyStore as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
- Use sterile technique.
- Protect from light and heat.
- Store refrigerated when appropriate.
- Use clean syringe-unit math before measuring.
Common Mistakes
- Confusing milligrams with milliliters.
- Choosing an option with awkward decimal units.
- Using too little liquid for very small measurements.
- Shaking the vial aggressively.
PT-141 (Bremelanotide) Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
PT-141, or bremelanotide, is a synthetic melanocortin-receptor agonist that's FDA-approved under the brand Vyleesi for premenopausal women with hypoactive sexual desire disorder. What makes it distinctive is where it acts: instead of increasing blood flow the way Viagra and Cialis (PDE5 inhibitors) do, it switches on MC4R receptors in the brain to raise sexual desire itself. It's actually a refined relative of Melanotan 2 — developed to keep the sexual effects while dialing down the tanning — which is why it can still cause mild skin darkening.
It's sold as a lyophilized powder, commonly in 10 mg vials, so add bacteriostatic water down the vial wall, swirl gently, and don't shake. As a worked example, a 10 mg vial with about 2.85 mL of bacteriostatic water gives 3.5 mg/mL, so the 1.75 mg dose used in the approved Vyleesi product is 0.5 mL — 50 units on a U-100 insulin syringe. Off-label male protocols often start lower (community reports commonly begin around 0.5 mg), and reconstituted vials should be kept refrigerated.
The evidence isn't symmetrical. For women, PT-141 has the strongest footing — the Phase 3 RECONNECT trials led to FDA approval for premenopausal HSDD, so its use in women is on-label. For men it's used off-label: there's Phase 2 data suggesting it can help erectile dysfunction, including in men who don't respond to Viagra-type drugs, but the male program was never completed and it isn't FDA-approved for men. Because MC4R signaling drives desire in both sexes, it's used across both, just with very different levels of formal backing.
Subcutaneous injection is the route with the real evidence — it's how Vyleesi is delivered and how the trials were run. A nasal spray exists and is sometimes compounded, but intranasal PT-141 is investigational, and in men the nasal program was actually stopped over blood-pressure spikes; absorption is also less consistent than injection. Oral and pill forms are marketed too, but as a peptide it's poorly absorbed by mouth, so injection remains the reference route.
The most common side effect by far is nausea — around 40% of women in trials — along with flushing, headache, and injection-site reactions. The one that deserves respect is a transient rise in blood pressure after dosing, which is why the label rules it out for anyone with uncontrolled hypertension or cardiovascular disease, and repeated frequent dosing can cause patchy skin darkening. Two clarifications worth making: PT-141 does not raise testosterone — it works on brain desire pathways, not hormones — and because of the blood-pressure effect, combining it with other sexual-function drugs is something to run past a doctor rather than do casually.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.
Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.